Bailard, Inc. Marker Therapeutics, Inc. Transaction History

Bailard, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 31, 2020	SELL	$2.68 - $4.85 $136,680 - $247,349	-51,000 Closed	0 $0
Q3 2019 Oct 18, 2019	BUY	$4.1 - $9.0 $41,000 - $90,000	10,000 Added 24.39%	51,000 $261,000
Q2 2019 Jul 26, 2019	BUY	$5.15 - $7.92 $51,500 - $79,200	10,000 Added 32.26%	41,000 $325,000
Q1 2019 Apr 24, 2019	BUY	$5.1 - $6.71 $51,000 - $67,100	10,000 Added 47.62%	31,000 $205,000
Q4 2018 Feb 05, 2019	BUY	$4.2 - $9.74 $88,200 - $204,540	21,000 New	21,000 $117,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $135M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.